Edward Stepanski, PhD

Dr Stepanski adds to the discussion on patient-reported outcomes in oncology with a counterpoint on the recent progress of these measures in trials and care settings. 
Edward J Stepanski discusses the underlying tension between payers and providers with respect to the aims of clinical pathways and the recent policy statement released by the American Society of Clinical Oncology.